These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14279228)

  • 1. AN ACTIVE STEREO-ISOMER (TRANS-FORM) OF AMCHA AND ITS ANTIFIBRINOLYTIC (ANTIPLASMINIC) ACTION IN VITRO AND IN VIVO.
    OKAMOTO S; SATO S; TAKADA Y; OKAMOTO U
    Keio J Med; 1964 Dec; 13():177-85. PubMed ID: 14279228
    [No Abstract]   [Full Text] [Related]  

  • 2. AMINO METHYL CYCLOHEXANE CARBOXYLIC ACID (AMCHA), A NEW SYNTHETIC FIBRINOLYTIC INHIBITOR.
    DUBBER AH; MCNICOL GP; DOUGLAS AS
    Br J Haematol; 1965 Mar; 11():237-45. PubMed ID: 14262183
    [No Abstract]   [Full Text] [Related]  

  • 3. [NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM].
    KUDRIASHOV BA; ANDREENKO GV; KALISHEVSKAIA TM
    Probl Gematol Pereliv Krovi; 1964 Apr; 9():12-5. PubMed ID: 14195816
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON THE DEFENSIVE REFLEX ANTIPLASMIN SYSTEM IN THE BODY].
    KUDRIASHOV BA; KALISHEVSKAIA TM
    Biull Eksp Biol Med; 1963 Sep; 56():29-33. PubMed ID: 14124776
    [No Abstract]   [Full Text] [Related]  

  • 5. ENHANCEMENT OF FIBRINOLYSIS AND ANTAGONISM OF ANTIPLASMIN BY REVERSIBLE PLASMIN INHIBITORS.
    MAXWELL RE; LEWANDOWSKI V; NICKEL VS
    Life Sci (1962); 1965 Jan; 4():45-51. PubMed ID: 14257064
    [No Abstract]   [Full Text] [Related]  

  • 6. [A NEW METHOD OF THE ANALYSIS OF EPSILON-AMINOCAPROIC ACID (EACA) AND AMINOMETHYLCYCLOHEXANE CARBOXYLIC ACID (AMCHA), THE POTENT ANTIFIBRINOLYTIC AGENTS].
    TAKATA Y; TAKATA A; OKAMOTO U
    Nihon Seirigaku Zasshi; 1964 May; 26():281-5. PubMed ID: 14172890
    [No Abstract]   [Full Text] [Related]  

  • 7. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INACTIVATION OF ANTIPLASMIN AND COMPLEMENT C1 IN HUMAN PLASMA RENDERED FIBRINOLYTIC BY SYNTHETIC ORGANIC COMPOUNDS.
    VONKAULLA KN
    Thromb Diath Haemorrh; 1963 Nov; 10():151-63. PubMed ID: 14081277
    [No Abstract]   [Full Text] [Related]  

  • 9. [STUDY OF THE ANTIFIBRINOLYTIC PROPERTIES OF KUNITZ'S PANCREATIC INHIBITOR. (TESTS IN VITRO AND IN VIVO)].
    GIBELLI A; SCARDI F
    Gazz Int Med Chir; 1963 Oct; 67():2105-16. PubMed ID: 14095279
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of Arthus tonsillitis by the administration of an antiplasminic agent.
    Kosugi T; Takagi I; Kinjo K; Nakagawa S; Noda Y; Mihara H
    Int J Tissue React; 1983; 5(2):205-15. PubMed ID: 6225744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observations on fibrinolysis; plasminogen, plasmin, and antiplasmin content of human blood.
    MACFARLANE RG; PILLING J
    Lancet; 1946 Oct; 2(6425):562-5. PubMed ID: 21001709
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical relevance and practical assessment of fibrinolysis shutdown.
    Moore HB; Moore BA; Sauaia A; Moore EE
    ANZ J Surg; 2020 Apr; 90(4):413-414. PubMed ID: 31535453
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research on the inhibitors of fibrinolysis: the methods of measuring antistreptokinase, antiplasmin and antitrypsin].
    GIACOMAZZI G
    Haematol Lat; 1961; 4():255-71. PubMed ID: 13898268
    [No Abstract]   [Full Text] [Related]  

  • 14. PROLONGED HYPERPLASMINEMIA WITH MITOMYCIN C IN RABBITS. REVERSIBLE DISAPPEARANCE OF TISSUE ACTIVATOR IN PARENCHYMA OF KIDNEY.
    OKAMOTO U; TAKADA Y
    Keio J Med; 1964 Sep; 13():165-72. PubMed ID: 14217475
    [No Abstract]   [Full Text] [Related]  

  • 15. Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma.
    Takahashi H; Koike T; Yoshida N; Kitahara O; Hanano M; Shibata A; Aoki N
    Am J Hematol; 1986 Oct; 23(2):153-66. PubMed ID: 2944378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ON THE EFFECT OF BLOOD COAGULATION INHIBITORS AND FIBRINOLYSIS ON THE SANARELLI-SHWARTZMAN PHENOMENON].
    HAUSTEIN KO; MARKWARDT F
    Thromb Diath Haemorrh; 1965 Mar; 13():60-4. PubMed ID: 14285979
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis.
    Booth NA; Bennett B
    Br J Haematol; 1984 Apr; 56(4):545-56. PubMed ID: 6201189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLINICAL USE OF AMCHA ON SEVERAL SKIN DISEASES (II).
    HATANO H; YAMAMOTO K
    Keio J Med; 1963 Sep; 12():113-6. PubMed ID: 14079728
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
    Kanamori N; Koiwa F; Uda S
    Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y; Watanabe K
    Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.